Sling Money Secures €13.6 Million in Series A Funding to Revolutionize Global Transfers

Sling Money, an innovative fintech company specializing in crypto-enabled money transfers, has successfully completed a €13.6 million ($15 million) Series A funding round. This significant investment was spearheaded by leading venture capital firms Union Square Ventures, Ribbit Capital, and Slow Ventures. The funding will be instrumental in advancing Sling Money’s mission to make international money…

Read More

UptimeAI Secures $14M Series A Funding to Revolutionize North American Industrial Plant Monitoring

In a significant leap forward for AI-driven industrial technology, UptimeAI has successfully closed a $14 million Series A funding round, spearheaded by WestBridge Capital with key contributions from Emergent Ventures and Aditya Birla Ventures. This latest infusion of capital marks a pivotal moment for UptimeAI, propelling its ambitious expansion across North America and solidifying its…

Read More

Amulet Secures $6 Million in Series A Funding to Revolutionize Food Allergen Detection

Amulet, an innovator in food safety technology, has successfully raised $5.8 million in Series A financing. This round, spearheaded by HealthX Ventures, also saw participation from Incite Ventures, AllerFund, Mendota Venture Capital, Great Oaks Venture Capital, and notable individuals including Pinterest executive Julie Bornstein and investor Diede van Lamoen. The investment will propel Amulet’s mission…

Read More

Gaussion Secures €11M to Revolutionize Battery Performance with Cutting-Edge Magnetic Technology

In a significant stride towards transforming battery technology, London-based magneto-electrochemistry pioneer, Gaussion, has successfully raised €11M in a Series A funding round. The round was led by Autotech Ventures, a prominent San Francisco-based venture capital firm, with continued support from existing backers BGF and the UCL Technology Fund. Managed by AlbionVC in collaboration with UCL…

Read More

Rapafusyn Pharmaceuticals Raises $28 Million to Revolutionize Drug Discovery with Innovative Molecular Glue Platform

Rapafusyn Pharmaceuticals, a trailblazer in the realm of therapeutic drug discovery, has announced a significant milestone with the closure of a Series A financing round, amassing $28 million. This strategic investment round was led by 3E Bioventures Capital and Proxima Ventures Ltd., with participation from Lapam Capital. Rapafusyn is spearheading the development of non-degrading molecular…

Read More